DiFusion has developed multiple patent pending MITA Technologies (Metallic Ion Therapeutic Agents) for antimicrobial, cellular repair, tissue regeneration, bone growth, scaffold construction and increased angiogenesis. Our first product CleanFuze™* was developed as an antimicrobial load-bearing biomaterial for orthopaedic applications and has proven highly successful in animal testing. CleanFuze™ is currently being scaled up for regulatory approval and commercialization. DiFusion is dedicated to leveraging these breakthroughs across multiple healthcare channels.